AngioDynamics Inc
ANGO10.560USD
+0.500+4.97%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
439.02MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über AngioDynamics Inc Unternehmen
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
AngioDynamics Inc Informationen
BörsenkürzelANGO
Name des UnternehmensAngioDynamics Inc
IPO-datumMay 27, 2004
CEOClemmer (James C)
Anzahl der mitarbeiter675
WertpapierartOrdinary Share
GeschäftsjahresendeMay 27
Addresse14 Plaza Drive
StadtLATHAM
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl12110
Telefon15187981215
Websitehttps://www.angiodynamics.com/
BörsenkürzelANGO
IPO-datumMay 27, 2004
CEOClemmer (James C)
Führungskräfte von AngioDynamics Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+890.00%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-36233.00%
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Independent Director
Independent Director
--
--
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Chad T. Campbell
Mr. Chad T. Campbell
Senior Vice President, General Manager - Global Oncology and Vascular Access
Senior Vice President, General Manager - Global Oncology and Vascular Access
--
--
Ms. Karen A. Licitra
Ms. Karen A. Licitra
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+890.00%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-36233.00%
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
66.46M
87.78%
International
9.26M
12.22%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Aktionärsstatistik
Aktualisiert: Wed, Feb 4
Aktualisiert: Wed, Feb 4
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Divisadero Street Capital Management, LP
8.92%
BlackRock Institutional Trust Company, N.A.
7.04%
Systematic Financial Management, L.P.
6.24%
Point72 Asset Management, L.P.
6.21%
The Vanguard Group, Inc.
5.91%
Andere
65.68%
Aktionäre
Aktionäre
Anteil
Divisadero Street Capital Management, LP
8.92%
BlackRock Institutional Trust Company, N.A.
7.04%
Systematic Financial Management, L.P.
6.24%
Point72 Asset Management, L.P.
6.21%
The Vanguard Group, Inc.
5.91%
Andere
65.68%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
35.12%
Investment Advisor/Hedge Fund
34.12%
Hedge Fund
19.12%
Individual Investor
6.43%
Venture Capital
3.46%
Research Firm
2.32%
Pension Fund
1.68%
Bank and Trust
0.25%
Insurance Company
0.03%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
311
40.19M
106.71%
-10.46K
2025Q3
344
40.20M
109.06%
+1.51M
2025Q2
370
37.97M
110.38%
+1.85M
2025Q1
372
36.50M
106.59%
-6.63M
2024Q4
361
34.34M
98.76%
+1.35M
2024Q3
371
33.44M
109.60%
-216.03K
2024Q2
370
33.66M
118.59%
-3.23M
2024Q1
368
36.03M
115.74%
-10.10M
2023Q4
378
37.01M
114.23%
+355.36K
2023Q3
364
36.64M
109.90%
-219.51K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Divisadero Street Capital Management, LP
3.68M
8.92%
+282.69K
+8.33%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.90M
7.04%
-61.07K
-2.06%
Sep 30, 2025
Systematic Financial Management, L.P.
2.57M
6.24%
+60.60K
+2.41%
Sep 30, 2025
Point72 Asset Management, L.P.
2.56M
6.21%
+609.91K
+31.29%
Sep 30, 2025
The Vanguard Group, Inc.
2.36M
5.74%
-125.09K
-5.03%
Sep 30, 2025
Armistice Capital LLC
1.64M
3.97%
+108.19K
+7.08%
Sep 30, 2025
Segall Bryant & Hamill, LLC
1.32M
3.2%
-37.14K
-2.74%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.16M
2.8%
-16.92K
-1.44%
Sep 30, 2025
Clemmer James C
1.13M
2.74%
+10.00K
+0.89%
Oct 09, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
State Street SPDR S&P Health Care Equipment ETF
0.79%
Invesco NASDAQ Future Gen 200 ETF
0.63%
Vanguard US Multifactor ETF
0.15%
iShares Micro-Cap ETF
0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.08%
Invesco Russell 2000 Dynamic Multifactor ETF
0.07%
Fidelity Enhanced Small Cap ETF
0.06%
Avantis US Small Cap Equity ETF
0.06%
Invesco RAFI US 1500 Small-Mid ETF
0.04%
iShares Russell 2000 Value ETF
0.02%
Mehr Anzeigen
State Street SPDR S&P Health Care Equipment ETF
Anteil0.79%
Invesco NASDAQ Future Gen 200 ETF
Anteil0.63%
Vanguard US Multifactor ETF
Anteil0.15%
iShares Micro-Cap ETF
Anteil0.09%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.08%
Invesco Russell 2000 Dynamic Multifactor ETF
Anteil0.07%
Fidelity Enhanced Small Cap ETF
Anteil0.06%
Avantis US Small Cap Equity ETF
Anteil0.06%
Invesco RAFI US 1500 Small-Mid ETF
Anteil0.04%
iShares Russell 2000 Value ETF
Anteil0.02%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
